뒤로
Broncus Holding Corporation(02216.HK) 가격
02216.HK 주가 차트
BRONCUS-B (02216.HK)
Broncus Holding Corporation
HK$0
0%
$0
정규장: Jan 20, 11:23:01 HKT
아직 데이터 없음Earnings FAQ
02216.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Broncus Holding Corporation 02216.HK의 지난 분기 매출 실적은 어땠나요?
Broncus Holding Corporation의 매출 추정치는 얼마인가요?
Broncus Holding Corporation의 수익 품질 점수는 얼마인가요?
Broncus Holding Corporation는 언제 수익을 보고하나요?
Broncus Holding Corporation의 예상 수익은 얼마인가요?
Broncus Holding Corporation은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$2.37
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
855.2K
EPS(TTM)
-0.23
배당수익률
--
시가총액
--
BRONCUS-B란 무엇인가요?
Broncus Holding Corp. engages in the research and development, and manufacturing, and commercialization of medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 193 full-time employees. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.